Updated Analysis of a Phase 1, Open-Label Study of LCAR-B38M, a Chimeric Antigen Receptor T Cell Therapy Directed Against B-Cell Maturation Antigen, in Patients with Relapsed/Refractory Multiple Myeloma | |
Zhao, Wan-Hong; Liu, Jie; Wang, Bai-Yan; Chen, Yin-Xia; Cao, Xing-Mei; Yang, Yun; Zhang, Yi-Lin; Wang, Fang-Xia; Zhang, Peng-Yu; Lei, Bo | |
2018 | |
卷号 | 132 |
会议录 | BLOOD |
URL标识 | 查看原文 |
ISSN号 | 0006-4971 |
内容类型 | 会议论文 |
URI标识 | http://www.corc.org.cn/handle/1471x/2922134 |
专题 | 西安交通大学 |
推荐引用方式 GB/T 7714 | Zhao, Wan-Hong,Liu, Jie,Wang, Bai-Yan,et al. Updated Analysis of a Phase 1, Open-Label Study of LCAR-B38M, a Chimeric Antigen Receptor T Cell Therapy Directed Against B-Cell Maturation Antigen, in Patients with Relapsed/Refractory Multiple Myeloma[C]. 见:. |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论